NEW SPS Webinars Announced!

The Safety Pharmacology Society is pleased to announce three NEW webinars to kick off 2015! In addition, the recording from the November Webinar on Cardiac Safety Testing is now available.


As a reminder, In order to view past and future SPS webinars, which are recorded and can be accessed at anytime, active membership in the Safety Pharmacology Society is required. 

Join the SPS community today!

Registration is now open for the January Webinar


Date/Time: January 29, 2015 11:00 AM ET
Title: Cross Species Translation of Drug-Induced Heart Rate and Blood Pressure Effects in Rat, Dog, and Nonhuman Primate to Human—How Predictive Are Preclinical Models?

Presenter: Jill Steidl-Nichols, PhD, Associate Research Fellow, Pfizer

Title: Nonclinical Cardiovascular Safety Testing: Moving Forward
Presenter:Douglas C. Throckmorton, MD, Deputy Director for Regulatory Programs, CDER, US FDA



Registration Coming Soon!

Date/Time: March 5, 2015 11:00 AM ET
Title: Safety Testing for Antiarrhythmic Drugs
Presenter: Michael J. Curtis, PhD, DSP, FHEA, FBPharmacolS, Cardiovascular Division, Faculty of Life Sciences & Medicine, Rayne Institute, King’s College London


Date/Time: April 16, 2015 11:00 AM ET
Title: Comprehensive In Vitro Proarrhythmia Assay (CIPA): An Update from An Industry Perspective
Presenters: Hugo Vargas, PhD, DSP, Scientific Director, Toxicology Sciences, Amgen, and Gary Gintant, PhD, Research Fellow, AbbVie



Safety Pharmacology Society Headquarters


Recent Stories
ICH E14 and S7B: A Note From the SPS President

ICH E14/S7B Q&As: Public Comment Closes Soon!

Webinar of Interest! An Update on COVID-19: Basic and Clinical Perspectives